Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Caspase-1 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody has been used in 29 publications
Supplier: Novus Biologicals NBP145433
Description
Caspase-1 Polyclonal specifically detects Caspase-1 in Human, Mouse, Rat, E. coli samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Knockdown Validated.Specifications
| Caspase-1 | |
| Polyclonal | |
| Unconjugated | |
| PBS (pH 7.2), 30% glycerol, 0.5% BSA, 0.5 mM EDTA with 0.03% Proclin 300 | |
| CASP-1, caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, caspase-1, EC 3.4.22, EC 3.4.22.36, ICEP45, IL-1 beta-converting enzyme, IL-1BC, IL1BC CASP1 nirs variant 1, IL1BCE, IL1B-convertase, interleukin 1-B converting enzyme, interleukin 1-beta convertase, Interleukin-1 beta convertase, Interleukin-1 beta-converting enzyme, p45 | |
| Rabbit | |
| Affinity Purified | |
| RUO | |
| Primary | |
| The immunoaffinity purified antibody recognizes 45 kDa procaspase-1 and the 20 kDa cleaved product. | |
| Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. |
| Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, KnockDown | |
| 0.5 mg/mL | |
| Western Blot 0.5 - 4 ug/ml, Immunohistochemistry, Immunocytochemistry/Immunofluorescence 10 - 20 ug/ml, Immunoprecipitation 4 - 8 ug/ml, Knockdown Validated | |
| NP_150636 | |
| CASP1 | |
| Synthetic peptide surrounding amino acid 132 of human caspase-1 (NP_150636). | |
| 0.1 mg | |
| Apoptosis, Cancer, Caspases | |
| 834 | |
| Human, Mouse, Rat, E. coli | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction